Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cytochrome P450 genotype-guided drug therapies: An update on current states.

Clinical and experimental pharmacology & physiology - 1 Oct 2018

Dong Amelia Nathania, Tan Boon Hooi, Pan Yan, Ong Chin Eng

Abstract excerpt

Over the past 2 decades, knowledge of the role and clinical value of pharmacogenetic markers has expanded so that individualized pre-emptive therapy based on genetic background of patients could be within reach for clinical implementation. This is evidenced from the frequent updating of drug labels that incorporates pharmacogenetic information (where compelling data become available) by the regulatory agencies...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiplatelet Therapy and Cardiovascular Diseases
Share to Cytochrome P-450 Enzyme System

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to Pharmacogenetics

Share to Pharmacogenetics and Drug Metabolism

Share to Polymorphism, Genetic

Source

Identifiers

PMID: 29858511
DOI: 10.1111/1440-1681.12978

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cytochrome P450 genotype-guided drug therapies: An update on current states.PMID 29858511Read ↗

Cytochrome P450 enzymes and genotype-guided drug therapy.Semantic proximity Read ↗

Pharmacogenetics Guidelines: Overview and Comparison of the DPWG, CPIC, CPNDS, and RNPGx GuidelinesSemantic proximity Read ↗

Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450-2C19 (CYP2C19) genotype and clopidogrel therapy.Semantic proximity Read ↗

Evidence based drug dosing and pharmacotherapeutic recommendations per genotype.Semantic proximity Read ↗

Pharmacogenetics-guided dose modifications of antidepressants.Semantic proximity Read ↗

Pharmacogenetics: From Bench to ByteSemantic proximity Read ↗

Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future.Semantic proximity Read ↗

Role of cytochrome P450 genotype in the steps toward personalized drug therapySemantic proximity Read ↗

Pharmacogenetics of antidepressant drugs: State of the art and clinical implementation - recommendations from the French National Network of Pharmacogenetics.Semantic proximity Read ↗

[How to individualize drug therapy based on pharmacogenetic information? A systematic review of published guidelines].Semantic proximity Read ↗

Genotype-guided warfarin therapy: current status.Semantic proximity Read ↗

Pharmacogenetics of drug metabolising enzymes: importance for personalised medicine.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.